Cargando…
Magnetism-mediated targeting hyperthermia-immunotherapy in “cold” tumor with CSF1R inhibitor
Background: Immunotherapy has profoundly changed the landscape of cancer management and represented the most significant breakthrough. Yet, it is a formidable challenge that the majority of cancers - the so-called “cold” tumors - poorly respond to immunotherapy. To find a general immunoregulatory mo...
Autores principales: | Fang, Yuefei, He, Yang, Wu, Canhao, Zhang, Meng, Gu, Zeyun, Zhang, Jiaxin, Liu, Ergang, Xu, Qin, Asrorov, Akmal M., Huang, Yongzhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171105/ https://www.ncbi.nlm.nih.gov/pubmed/34093858 http://dx.doi.org/10.7150/thno.57511 |
Ejemplares similares
-
Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona
por: He, Yang, et al.
Publicado: (2022) -
Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents
por: Asrorov, Akmal M., et al.
Publicado: (2022) -
Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
por: Zhang, Meng, et al.
Publicado: (2017) -
Recombinant cell-penetrating trichosanthin synergizes anti-PD-1 therapy in colorectal tumor
por: Zhang, Meng, et al.
Publicado: (2023) -
Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia
por: Dias, Alexandre M. M., et al.
Publicado: (2022)